相关实验视频

Updated: Jul 18, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

降低BTK对肺腺癌生长和免疫反应的影响

Jilan Huang^1,2, Yufan Yuan^1,2, Linghong Guo^1,2

¹Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

|December 4, 2024

概括

低布鲁顿的氨酸激酶 (BTK) 表达预测肺腺癌 (LUAD) 的不良结果. 由于BTK缺乏加速了LUAD的进展,并降低了抗瘤免疫力,这表明BTK是潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

肺腺癌 (LUAD) 是癌症死亡的主要原因.
对于LUAD进展和免疫规避的分子驱动因素仍然不完全理解.
布鲁顿氨酸激酶 (BTK) 与各种癌症有关,但其在LUAD中的作用尚未完全阐明.

研究的目的:

研究BTK在LUAD进展和患者预后中的作用.
探索BTK作为LUAD潜在的治疗点.

主要方法:

放射学模型整合了BTK表达,PET-CT数据 (DeeplabV3) 和TCGA转录基因/临床数据.
在体外细胞系实验.
在体内小鼠模型 (异种移植和正管植入).

主要成果:

低BTK表达与较差的LUAD患者预后有很强的相关性.
在实验模型中,BTK缺乏会增强LUAD细胞的增殖,侵入和转移.
在体内,BTK的抑制导致瘤生长的增加和CD8+T细胞活性的减少,这表明免疫抑制.

结论:

BTK在调节LUAD进展和瘤免疫微环境方面发挥着重要作用.
缺乏BTK促进了LUAD的攻击性和免疫规避.
针对BTK可能是LUAD的一种有前途的治疗策略.

关键词:

这就是BTK基因.CD8+ T 细胞 CD8+ T 细胞在PET-CT中使用PET-CT.肺部腺癌瘤是什么无线电学模型的放射学模型.转录组学转录组学是指转录组学.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...